Long-term reduction of vasopressin excretion induced by the central injection of an immunoconjugate (antibody to vasopressin linked to ricin A chain).
We have previously demonstrated that vasopressin-producing neurons are the target of monoclonal antibodies to vasopressin microinjected into the brain tissue. At the same time, this central microinjection of vasopressin-monoclonal antibody into the supraoptic nuclei produced hydro-osmotic disorders mimicking the effects of a central diabetes insipidus. In order to investigate the increase in both duration and amplitude of the biological effects seen after the injection of vasopressin-monoclonal antibody, an immunoconjugate was constructed with the vasopressin-monoclonal antibody IgG1k isotype and the cytotoxic part of the ricin molecule, the ricin A chain. The biological parameters, such as diuresis and urine osmolality which are directly regulated by vasopressin, and vasopressin excretion, were measured after the central injection of this immunotoxin/immunoconjugate. The consequences of immunotoxin injection were also studied when immunotoxin was co-injected with monensin (50 nM) which has been shown to decrease the intracellular degradation of immunotoxin, and plasma complement, which has been shown to increase the neuronal uptake of immunotoxin. Single injection of immunotoxin near the hypothalamic supraoptic nuclei significantly increased diuresis and decreased vasopressin excretion. However, these effects were only transient and disappeared 24 h later. Four successive injections of immunotoxin (one per day) with monensin induced a decrease of vasopressin excretion which was still observed after a resting period of four days after the fourth injection. The long-term reduction of vasopressin excretion was induced in rats receiving four successive injections of a mixture consisting of immunotoxin with monensin and plasma complement. In such experiments, the vasopressin content of urine remained low (55% under the baseline value), two weeks after the fourth injection of immunotoxin. At the same time, the diuresis was increased (80% above the baseline value) and urine osmolality lowered (45% under the baseline value). When non-specific IgG replaced specific antibody, vasopressin excretion, diuresis as well as urine osmolality were unchanged. The results of this study demonstrated that the use of a specific immunotoxin results in a local interference with the vasopressinergic neurons and induces a long-term reduction of vasopressin secretion.
Burlet
A
A
Laboratorie de Biologie cellulaire, INSERM U308-CNRS SDI 15769 I, Nancy, France.
Chapleur-Chateau
M
M
Haumont-Pellegri
B
B
Jansen
F
F
Menzaghi
F
F
Fernette
B
B
Nicolas
J P
JP
Burlet
C
C
D000818:Animals; D000906:Antibodies / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D000918:Antibody Specificity; D001127:Arginine Vasopressin / Q000276:immunology / Q000652:urine*; D004231:Diuresis / Q000187:drug effects; D004326:Drinking / Q000502:physiology; D007074:Immunoglobulin G / Q000276:immunology; D000922:Immunotoxins / Q000276:immunology; D008297:Male; D008985:Monensin / Q000494:pharmacology; D009994:Osmolar Concentration; D051381:Rats; D012276:Ricin / Q000276:immunology*; D014563:Urodynamics / Q000502:physiology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D000922:Immunotoxins; D001127:Arginine Vasopressin; D012276:Ricin; D008985:Monensin